Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Oxedrine Tartrate
2. Corvasymton
3. Simpadren
4. Sympathomim
5. 16589-24-5
6. Cardiodinamin
7. 9i99i5995j
8. Sympacor
9. Sympalept
10. Sympatizin
11. (2r,3r)-2,3-dihydroxybutanedioic Acid;4-[1-hydroxy-2-(methylamino)ethyl]phenol
12. Synephrinium Tartaricum
13. Sinefrina Tartrato
14. Sinefrina Tartrato [italian]
15. Einecs 200-642-3
16. P-hydroxyphenylmethylaminoaethanoltartrat
17. Oxyphenyl-methylamino-aethanolum Tartaricum
18. Unii-9i99i5995j
19. Einecs 240-647-8
20. Dacryoboraline (tn)
21. (+-)-1-(4-hydroxyphenyl)-2-methylaminoethanol Tartrate
22. (+-)-1-(4-idrossifenil)-2-metilaminoetanolo Tartrato [italian]
23. Bis(rs)-4-hydroxy-alpha-(methylaminomethyl)benzylalkohol)-(rr)-tartrat
24. Synephrine Tartrate (salt)
25. Oxedrine Hemitartrate
26. (+-)-1-(4-idrossifenil)-2-metilaminoetanolo Tartrato
27. Synephrine Tartrate [mi]
28. Synephrine Tartrate, Dl-
29. Dtxsid10985819
30. Oxedrine Tartrate [mart.]
31. Oxedrine Tartrate [who-dd]
32. Bcp13680
33. Mfcd00151120
34. 2,3-dihydroxybutanedioic Acid,4-[1-hydroxy-2-(methylamino)ethyl]phenol
35. Akos015909769
36. Benzyl Alcohol, P-hydroxy-alpha-((methylamino)methyl)-, Tartrate (2:1) (salt)
37. As-74464
38. D08308
39. D92240
40. Q27272589
41. (rs)-1-(4-hydroxyphenyl)-2-(methylamino)ethanol Tartrate
42. Bis((beta,4-dihydroxyphenethyl)methylammonium) (r-(r*,r*))-tartrate
43. (2r,3r)-2,3-dihydroxybutanedioic Acid; Bis(4-[1-hydroxy-2-(methylamino)ethyl]phenol)
44. 2,3-dihydroxybutanedioic Acid--4-[1-hydroxy-2-(methylamino)ethyl]phenol (1/2)
45. Benzenemethanol, 4-hydroxy-.alpha.-((methylamino)methyl)-, (2r,3r)-2,3-dihydroxybutanedioate (2:1)
46. Benzenemethanol, 4-hydroxy-alpha-((methylamino)methyl)-, (2r,3r)-2,3-dihydroxybutanedioate (2:1) (salt)
47. Benzenemethanol, 4-hydroxy-alpha-((methylamino)methyl)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (2:1) (salt)
| Molecular Weight | 484.5 g/mol |
|---|---|
| Molecular Formula | C22H32N2O10 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 9 |
| Exact Mass | 484.20569522 g/mol |
| Monoisotopic Mass | 484.20569522 g/mol |
| Topological Polar Surface Area | 220 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 256 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Cardiodinamin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cardiodinamin, including repackagers and relabelers. The FDA regulates Cardiodinamin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cardiodinamin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cardiodinamin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cardiodinamin supplier is an individual or a company that provides Cardiodinamin active pharmaceutical ingredient (API) or Cardiodinamin finished formulations upon request. The Cardiodinamin suppliers may include Cardiodinamin API manufacturers, exporters, distributors and traders.
click here to find a list of Cardiodinamin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cardiodinamin written confirmation (Cardiodinamin WC) is an official document issued by a regulatory agency to a Cardiodinamin manufacturer, verifying that the manufacturing facility of a Cardiodinamin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cardiodinamin APIs or Cardiodinamin finished pharmaceutical products to another nation, regulatory agencies frequently require a Cardiodinamin WC (written confirmation) as part of the regulatory process.
click here to find a list of Cardiodinamin suppliers with Written Confirmation (WC) on PharmaCompass.
Cardiodinamin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cardiodinamin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cardiodinamin GMP manufacturer or Cardiodinamin GMP API supplier for your needs.
A Cardiodinamin CoA (Certificate of Analysis) is a formal document that attests to Cardiodinamin's compliance with Cardiodinamin specifications and serves as a tool for batch-level quality control.
Cardiodinamin CoA mostly includes findings from lab analyses of a specific batch. For each Cardiodinamin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cardiodinamin may be tested according to a variety of international standards, such as European Pharmacopoeia (Cardiodinamin EP), Cardiodinamin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cardiodinamin USP).
LOOKING FOR A SUPPLIER?
